Effect of colloidal silicon dioxide and moisture on powder flow properties: Predicting in-process performance using image-based analysis

[Display omitted] The effect of colloidal silicon dioxide (CSD) on powder flow properties of poor-flowing excipient lactose 200 M was investigated. Binary mixtures of different ratios of CSD as glidant were examined using a modern image-based flow measuring technique. Special attention was placed to...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of pharmaceutics Vol. 597; p. 120344
Main Authors Blanco, David, Antikainen, Osmo, Räikkönen, Heikki, Yliruusi, Jouko, Juppo, Anne Mari
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 15.03.2021
Subjects
Cohesive powders
Colloidal silicon dioxide
Image analysis
Lactose
Moisture
Powder flow
Tablet manufacture
Powder flow
Tablet manufacture
Lactose
Image analysis
Moisture
Colloidal silicon dioxide
Cohesive powders
Online AccessGet full text

Cover

More Information
Summary:[Display omitted] The effect of colloidal silicon dioxide (CSD) on powder flow properties of poor-flowing excipient lactose 200 M was investigated. Binary mixtures of different ratios of CSD as glidant were examined using a modern image-based flow measuring technique. Special attention was placed to subtle variations in powder flow from small changes in glidant concentration (0.025% w/w). Understanding the modes of interaction of particles and their effects on flowability using the method predicted the die filling performance during tablet manufacture. In addition, the importance of moisture content on powder flow properties was empirically underlined. A more efficient range of CSD was detected from 0.10 to 0.50% w/w in most of the tested conditions, which revealed a significant improvement in powder flow performance compared to higher amounts typically handled in the pharmaceutical industry.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0378-5173
1873-3476
DOI:10.1016/j.ijpharm.2021.120344